Olaparib available first line in Scotland for BRCA+ women

[OvacomeSupport]

Hello All

This is just to let you know that the Scottish Medicines Consortium (SMC) has today announced that olaparib will be available as first line maintenance treatment for stage 3 and 4 high grade serous ovarian, fallopian tube and peritoneal cancer, for women with the BRCA mutation who have responded to platinum chemotherapy.

There is more information on the SMC website here: scottishmedicines.org.uk/me...

Best wishes

Anna

Ovacome Support